To investigate the potential role of cGAS-STING pathway activation in response immunotherapy and its association with CIN, we endeavored to develop a model based on the expression levels of genes with known involvement in the cGAS-STING pathway (Fig. 1A). This evidence concerns the gene STING1 and cervical squamous intraepithelial neoplasia.